Acta Med. 2019, 62: 1-5

https://doi.org/10.14712/18059694.2019.38

Dual Tracer 99mTc-Pertechnetate/99mTc-MIBI Dual-Time-Point SPECT/CT Parathyroid Gland Assessment Regarding to Parathyroid Gland Size and Biochemical Parameters – Two Years Single Imaging Centre Experience

Eva Krčálováa,b, Jiří Horáčeka,c, Edita Novákovád, Miroslav Cvejne, Daša Lazarákováf, Radek Mikuleckýf, Jiří Máslog, Jitka Čepkováh, Jan Tilšerb, Jiří Doležalb

aAcademic Department of Internal Medicine, Charles University, Faculty of Medicine in Hradec Králové, Czech Republic
bNuclear Medicine Department, University Hospital Hradec Králové, Czech Republic
c4th Department of Internal Medicine, Charles University, Faculty of Medicine in Hradec Králové and University Hospital Hradec Králové, Czech Republic
dNáchod Hospital Internal Medicine Department, Czech Republic
ePrivate Endocrinology Outpatient Clinic, Náchod, Czech Republic
fPardubice Hospital Internal Medicine Department, Czech Republic
gNáchod Hospital Osteology Outpatient Clinic, Czech Republic
hDepartment of Clinical Biochemistry, Faculty of Medicine Hradec Králové and University Hospital Hradec Králové

Received November 27, 2018
Accepted December 6, 2018

References

1. Zajíčková K. Primární hyperparatyreóza - nové klinické formy onemocnění. Vnitř Lék 2017; 63(9): 604–8.
2. Insogna KL. Primary Hyperparathyroidism. N Engl J Med 2018; 379(11): 1050–9. <https://doi.org/10.1056/NEJMcp1714213>
3. Betka J, Astl J, Chovanec M, Lukeš P, Zábrodský M, Plzák J. Minimálně invazivní endoskopická chirurgie štítné žlázy a příštítných tělísek. Endoskopie 2009; 18(3): 112–5.
4. Mettler FA, Guiberteau MJ. Essentials of nuclear medicine imaging. 6th ed. Philadelphia: Elsevier Saunders, 2012: 126–36.
5. Ziessman HA, O’Malley JP, Thrall JH, Fahey FH. Nuclear medicine: The requisites. Philadelphia: Elsevier Saunders, 2014: 92.
6. Hindié E, Ugur Ö, Fuster D, et al. 2009 EANM parathyroid guidelines. Eur J Nucl Med Mol Imaging 2009; 36(7): 1201–16. <https://doi.org/10.1007/s00259-009-1131-z>
7. Almquist M, Bergenfelz A, Mårtensson H, Thier M, Nordenström E. Changing biochemical presentation of primary hyperparathyroidism. Langenbecks Arch Surg 2010; 395(7): 925–8. <https://doi.org/10.1007/s00423-010-0675-5>
8. Raruenrom Y, Theerakulpisut D, Wongsurawat N, Somboonporn C. Diagnostic accuracy of planar, SPECT, and SPECT/CT parathyroid scintigraphy protocols in patients with hyperparathyroidism. Nucl Med Rev Cent East Eur 2018; 21(1): 20–5. <https://doi.org/10.5603/NMR.a2018.0003>
9. Neumann DR, Obuchowski NA, DiFilippo FP. Preoperative 123I/99mTc-Sestamibi Subtraction SPECT and SPECT/CT in Primary Hyperparathyroidism. J Nucl Med 2008; 49: 2012–7. <https://doi.org/10.2967/jnumed.108.054858>
10. Beheshti M, Hehenwarter L, Paymani Z, et al. 18F-Fluorocholine PET/ CT in the assessment of primary hyperparathyroidism compared with 99mTc-MIBI or 99mTc-tetrofosmin SPECT/CT: a prospective dual- centre study in 100 patients. Eur J Nucl Med Mol Imaging 2018; 45(10): 1762–71. <https://doi.org/10.1007/s00259-018-3980-9> <PubMed>
11. Koranda P, Halenka M, Zahálková J, Kosatíková Z , MyslivečekM. Jednodenní scintigrafické vyšetření kombinující 99mTc MIBI/ 99mTcO4 subtrakci a dvoufázvou 99mTc-MIBI scintigrafii a SPECT u pacientů s terciární hyperparatyreózou. Ces Radiol 2010; 64(3): 192–7.
12. Westerdahl J, Bergenfelz A. Sestamibi scan-directed parathyroid surgery: potentially high failure rate without measurement of intraoperative parathyroid hormone. World J Surg 2004; 28(11): 1132–8. <https://doi.org/10.1007/s00268-004-7484-3>
13. Hoang TD, Jani AG, Mai VQ, Tuamokumo FO, Shakir MKM. Associations of serum ionized calcium, phosphate and PTH levels with technetium-99 sestamibi parathyroid SPECT/CT scan in primary hyperparathyroidism. Endocr Pract 2019; 25(1): 16–22. <https://doi.org/10.4158/EP-2018-0414>
14. Dy BM, Richards ML, Vazquez BJ, Thompson GB, Farley DR, Grant CS. Primary hyperparathyroidism and negative Tc99 sestamibi imaging: to operate or not? Ann Surg Oncol 2012; 19(7): 2272–8. <https://doi.org/10.1245/s10434-012-2325-3>
15. Broulík P. Hyperkalcemie: na co je třeba myslet a jaká vyšetření provést? Interní Med 2011; 13(7–8): 314–7.
16. Silverberg SJ, Clarke BL, Peacock M, et al. Current issues in the presentation of asymptomatic primary hyperparathyroidism: proceedings of the Fourth International Workshop. J Clin Endocrinol Metab 2014; 99(10): 3580–94. <https://doi.org/10.1210/jc.2014-1415> <PubMed>
17. Udelsman R, Akerstrom G, Biagini C, et al. The surgical management of asymptomatic primary hyperparathyroidism: proceedings of the Fourth International Workshop. J Clin Endocrinol Metab 2014; 99(10): 3595–606. <https://doi.org/10.1210/jc.2014-2000>
18. Chroustova D, Kubinyi J, Trnka J, Adamek S. The role of 99mTc-MIBI SPECT/low dose CT with 3D subtraction in patients with secondary hyperparathyroidism due to chronic kidney disease. Endocr Regul 2014; 48(2): 55–63. <https://doi.org/10.4149/endo_2014_02_55>
19. Huber GF, Hullner M, Schmid C, et al. Benefit of (18)F-fluorocholine PET imaging in parathyroid surgery. Eur Radiol 2018; 28(6): 2700–7. <https://doi.org/10.1007/s00330-017-5190-4>
20. Kluijfhout WP, Pasternak JD, Drake FT, et al. Use of PET tracers for parathyroid localization: a systematic review and meta-analysis. Langenbecks Arch Surg 2016; 401(7): 925–35. <https://doi.org/10.1007/s00423-016-1425-0> <PubMed>
front cover

ISSN 1211-4286 (Print) ISSN 1805-9694 (Online)

Open access journal

Archive